As of Jan 13
| -0.125 / -0.99%|
The 7 analysts offering 12-month price forecasts for Sucampo Pharmaceuticals Inc have a median target of 19.00, with a high estimate of 29.00 and a low estimate of 14.00. The median estimate represents a +52.00% increase from the last price of 12.50.
The current consensus among 7 polled investment analysts is to Buy stock in Sucampo Pharmaceuticals Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.